NCT04449588 - Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS | Biotech Hunter

Enrollment

369

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

March 26, 2024

Study Completion Date

March 26, 2024

Conditions

COVID-19 Pneumonia

Interventions

DRUG

BDB-001 Injection

BDB-001 Injection+Conventional treatment

OTHER

Conventional treatment

Conventional treatment only. Local guidelines should be integrated to choose the best supportive care.

Trial Locations (12)

RSUD Cengkareng(Cengkareng General Hospital), Jakarta

RSUD Pasar Minggu(Pasar Minggu General Hospital), Jakarta

RSUP Persahabatan(Persahabatan General Hospital), Jakarta

Southwest Hospital Chongqing, Chongqing

Asgar Ali Hospital, Dhaka

Bangladesh Specialized Hospital, Dhaka

Noble Hospital Pvt Ltd, Nagpur

Government Medical College and Hospital, Pune

Hospital Universitario 12 De Octubre, Madrid

Hospital Universitario Clínico San Carlos, Madrid

Hospital Universitario de la Princesa, Madrid

Hospital Universitario Fundación Díaz, Madrid